Literature DB >> 29087147

Health insurance and racial disparities in pulmonary hypertension outcomes.

Kishan S Parikh, Kathryn A Stackhouse, Stephen A Hart, Thomas M Bashore, Richard A Krasuski1.   

Abstract

OBJECTIVES: Pulmonary hypertension portends a poorer prognosis for blacks versus white populations, but the underlying reasons are poorly understood. We investigated associations of disease characteristics, insurance status, and race with clinical outcomes. STUDY
DESIGN: Retrospective cohort study of patients presenting for initial pulmonary hypertension evaluation at 2 academic referral centers.
METHODS: We recorded insurance status (Medicare, Medicaid, private, self-pay), echocardiographic, and hemodynamics data from 261 patients (79% whites, 17% blacks) with a new diagnosis of pulmonary hypertension. Subjects were followed for 2.3 years for survival. Adjustment for covariates was performed with Cox proportional hazards modeling.
RESULTS: Compared with white patients, blacks were younger (50 ± 15 vs 53 ± 12 years; P = .04), with females representing a majority of patients in both groups (80% vs 66%; P = .08) and similar functional class distribution (class 2/3/4: 30%/52%/16% blacks vs 33%/48%/14% whites; P = .69). Blacks diagnosed with incident pulmonary hypertension were more frequently covered by Medicaid (12.5% vs 0.7%) and had less private insurance (50% vs 61%; P = .007) than whites. At presentation, blacks had more right ventricular dysfunction (P = .04), but similar mean pulmonary arterial pressure (46 vs 45 mm Hg, respectively; P = .66). After adjusting for age and functional class, blacks had greater mortality risk (hazard ratio [HR], 2.06; 95% confidence interval [CI], 1.18-3.44), which did not differ by race after additional adjustment for insurance status (HR, 1.74; 95% CI, 0.84-3.32; P =.13).
CONCLUSIONS: In a large cohort of patients with incident pulmonary hypertension, black patients had poorer right-side heart function and survival rates than white patients. However, adjustment for insurance status in our cohort removed differences in survival by race.

Entities:  

Mesh:

Year:  2017        PMID: 29087147

Source DB:  PubMed          Journal:  Am J Manag Care        ISSN: 1088-0224            Impact factor:   2.229


  9 in total

1.  Racial and Ethnic Differences in Pediatric Pulmonary Hypertension: An Analysis of the Pediatric Pulmonary Hypertension Network Registry.

Authors:  Mei-Sing Ong; Steve Abman; Eric D Austin; Jeffrey A Feinstein; Rachel K Hopper; Usha S Krishnan; Mary P Mullen; Marc D Natter; J Usha Raj; Erika B Rosenzweig; Kenneth D Mandl
Journal:  J Pediatr       Date:  2019-06-05       Impact factor: 4.406

2.  Contraceptive use among women with cystic fibrosis: A pilot study linking reproductive health questions to the Cystic Fibrosis Foundation National Patient Registry.

Authors:  Emily M Godfrey; Sheila Mody; Malaika R Schwartz; Sonya L Heltshe; Jennifer L Taylor-Cousar; Raksha Jain; Sandra Sufian; Tatiana Josephy; Moira L Aitken
Journal:  Contraception       Date:  2020-02-26       Impact factor: 3.375

3.  Association between Pulmonary Hypertension and Clinical Outcomes in Hospitalized Patients with Sickle Cell Disease.

Authors:  Manyoo A Agarwal; Mahek Shah; Brijesh Patel; Vikki G Nolan; Guy L Reed; Ronald J Oudiz; Gaurav Choudhary; Bradley A Maron
Journal:  Am J Respir Crit Care Med       Date:  2018-08-15       Impact factor: 21.405

4.  Pulmonary arterial capacitance predicts outcomes in patients with pulmonary hypertension independent of race/ethnicity, sex, and etiology.

Authors:  Jacob J Mayfield; Alexander Papolos; Elena Vasti; Teresa De Marco; Geoffrey H Tison
Journal:  Respir Med       Date:  2020-02-04       Impact factor: 3.415

5.  Pulmonary Hypertension Subtypes and Mortality in CKD.

Authors:  Daniel L Edmonston; Kishan S Parikh; Sudarshan Rajagopal; Linda K Shaw; Dennis Abraham; Alexander Grabner; Matthew A Sparks; Myles Wolf
Journal:  Am J Kidney Dis       Date:  2019-11-12       Impact factor: 8.860

6.  Deconstructing the Melting Pot in Pulmonary Arterial Hypertension.

Authors:  Eric D Austin; Rizwan Hamid
Journal:  Am J Respir Crit Care Med       Date:  2020-06-01       Impact factor: 21.405

7.  Scaling a Community-Wide Campaign Intervention to Manage Hypertension and Weight Loss.

Authors:  Belinda M Reininger; Lisa A Mitchell-Bennett; MinJae Lee; Paul G Yeh; Amanda C Davé; Soo Kyung Park; Tianlin Xu; Alma G Ochoa-Del Toro
Journal:  Front Med (Lausanne)       Date:  2021-11-22

8.  Prediction of patient outcomes through social determinants of health: The Pulmonary Hypertension Association Registry (PHAR) evaluation.

Authors:  Dan Grinnan; Le Kang; Christine DeWilde; David Badesch; Raymond Benza; Todd Bull; Murali Chakinala; Teresa DeMarco; Jeremy Feldman; Hubert J Ford; James Klinger; John McConnell; Erika B Rosenzweig; Jeffrey Sager; Oksana Shlobin; Roham Zamanian
Journal:  Pulm Circ       Date:  2022-07-01       Impact factor: 2.886

9.  Racial differences in patients referred for right heart catheterization and risk of pulmonary hypertension.

Authors:  Bin Q Yang; Tufik R Assad; Jared M O'Leary; Meng Xu; Stephen J Halliday; Reid W D'Amico; Eric H Farber-Eger; Quinn S Wells; Anna R Hemnes; Evan L Brittain
Journal:  Pulm Circ       Date:  2018-02-26       Impact factor: 3.017

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.